--- title: "CATHVISION ApS – CVR 35205500, financials and ownership" description: "CATHVISION ApS (CVR 35205500): CathVision develops electrophysiology solutions centered on an innovative EP recording system and AI-based analytic tools to support the diagnosis, characterization, and treatment of cardiac arrhythmias." canonical_url: "https://datapublica.dk/en/companies/35205500-cathvision-aps" locale: "en" route_type: "company_overview" robots: "index,follow" --- # CATHVISION ApS CATHVISION ApS \(CVR 35205500\): CathVision develops electrophysiology solutions centered on an innovative EP recording system and AI-based analytic tools to support the diagnosis, characterization, and treatment of cardiac arrhythmias. CVR number: 35205500 ## Company details - **CVR number:** 35205500 - **Status:** Aktiv - **Address:** Lygten 37, 2400, København NV - **Legal form:** Anpartsselskab \(ApS\) - **Founded:** Mar 25, 2013 - **Employees / FTEs:** 20 / 14 - **Production units:** 1 - **Website:** https://cathvision.com/ - **LinkedIn:** cathvision ## Description CathVision develops electrophysiology solutions centered on an innovative EP recording system and AI-based analytic tools to support the diagnosis, characterization, and treatment of cardiac arrhythmias. CathVision develops EP recording technology and AI-based analytic tools that help electrophysiologists and physicians make more informed clinical decisions and improve the diagnosis and treatment of cardiac arrhythmias. ### Company's own description on virk.dk The Company operates within the medical technology sector and is engaged in the development and commercialization of advanced electrophysiology solutions. Its activities primarily comprise the design and development of technology for measuring and analysing cardiac electrical signals, including proprietary electrophysiology recording systems and AI-based analytical software used in the diagnosis and treatment of cardiac arrhythmias. The Company’s solutions are intended for use by electrophysiologists and hospitals, supporting clinical decision-making and improving patient outcomes through enhanced signal acquisition, analysis and interpretation. In addition, the Company undertakes research and development activities within natural sciences and technical domains, including clinical validation and continuous innovation of its technology platforms and related products. During 2025, CathVision continued development of its ECGenius™ system, releasing multiple versions \(3.3, 3.3.2, 3.4, and 3.5\). These releases introduced incremental clinical and commercial functionality and supported expansion into European markets. In parallel, development activities progressed on the Cardialytics™ platform, including the PFAanalyzer™ product development. The development efforts also resulted in five new patent applications, increasing the total IP portfolio to 20 active patent families. 2025 long term installations with daily usage at reference sites in the US market demonstrated clinical & commercial readiness of the product supporting larger scale market adoption in 2026. ### Products & services ECGenius™ System • CARDIALYTICS™ AI-based analytic tools • EP recording technology • Cardiac electrical signal acquisition, interpretation, and therapy support ### Industries Healthcare ### Customer types Electrophysiologists • Physicians ## Activities and industry - Forskning og eksperimentel udvikling inden for naturvidenskab og teknik - 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik ## Latest financial period - **Reporting period:** 2025 - **Currency:** DKK - **Gross profit:** -13,538,371 - **Operating profit:** -37,764,008 - **Profit after tax:** -36,136,013 - **Assets:** 101,889,646 - **Equity:** 80,093,733 ## Founders | Founder | Registered as founder | Current roles | Ownership | | --- | --- | --- | --- | | [Lasse Emil Holmegaard Korff](https://datapublica.dk/en/people/pid_entity_4000638046-lasse-emil-holmegaard-korff) | Mar 25, 2013 | — | — | | [Mads Emil Matthiesen](https://datapublica.dk/en/people/pid_entity_4000697067-mads-emil-matthiesen) | Mar 25, 2013 | Management | 5–9.99 % / Indirect via [Healthcare Ventures ApS](https://datapublica.dk/en/companies/36537728-healthcare-ventures-aps) | | [Rune Justesen Ørndrup](https://datapublica.dk/en/people/pid_entity_4000697069-rune-justesen-rndrup) | Mar 25, 2013 | — | — | | [Rune Tore Mondadori Paamand](https://datapublica.dk/en/people/pid_entity_4000697068-rune-tore-mondadori-paamand) | Mar 25, 2013 | — | — | ## People | Person | Roles | Titles | | --- | --- | --- | | [Tonni Bülow-Nielsen](https://datapublica.dk/en/people/pid_entity_4000721093-tonni-b-low-nielsen) | Board | BESTYRELSESMEDLEM | | [Allan Renneberg Gersfelt-Larsen](https://datapublica.dk/en/people/pid_entity_4000588796-allan-renneberg-gersfelt-larsen) | Management | DIREKTØR | | [Mads Emil Matthiesen](https://datapublica.dk/en/people/pid_entity_4000697067-mads-emil-matthiesen) | Management | ADM. DIR. | ## Auditor | Audit firm | Auditor | Role | From | | --- | --- | --- | --- | | EY Godkendt Revisionspartnerselskab | Anders Roe Eriksen | State Authorised Public Accountant | Jun 30, 2026 | ## Contact ### From [cvr.dk](https://datacvr.virk.dk/) Advertising protected Contact details from CVR must not be used for direct marketing when the entity is advertising protected. The protection does not cover details collected from the company’s own website. The general marketing rules still apply. [Read more at the Danish Business Authority](https://virksomhedsguiden.dk/content/ydelser/faa-reklamebeskyttet-din-virksomhed-i-cvr/3337006d-3b93-4bb0-bc08-82a0915c0332/) | Contact | Phone | Email | | --- | --- | --- | | Company | 3147\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F35205500-cathvision-aps) | co\*\*\*\*\*@cathvision.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F35205500-cathvision-aps) | ### From [cathvision.com](https://cathvision.com/) | Contact | Phone | Email | | --- | --- | --- | | Main | — | co\*\*\*\*\*@cathvision.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F35205500-cathvision-aps) / m\*\*@cathvision.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F35205500-cathvision-aps) | | Support | — | su\*\*\*\*\*@cathvision.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F35205500-cathvision-aps) | | Connect With Us | +45 31 47 \*\* \*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F35205500-cathvision-aps) | — | ## Legal owners ### Current | Owner | Ownership | Voting rights | From | | --- | --- | --- | --- | | OwnerGrac Société Simple | Ownership33.33–49.99 % | Voting rights33.33 % | FromSep 24, 2026 | | OwnerDanmarks Eksport- og Investeringsfond | Ownership25–33.32 % | Voting rights25 % | FromAug 18, 2026 | | OwnerHealthcare Ventures ApS | Ownership5–9.99 % | Voting rights5 % | FromMay 23, 2017 | ### Previous | Owner | Ownership | Voting rights | From | To | | --- | --- | --- | --- | --- | | OwnerGrac Société Simple | Ownership33.33–49.99 % | Voting rights33.33 % | FromAug 18, 2026 | ToSep 23, 2026 | | OwnerDanmarks Eksport- og Investeringsfond | Ownership33.33–49.99 % | Voting rights33.33 % | FromApr 1, 2023 | ToAug 17, 2026 | | OwnerGrac Société Simple | Ownership33.33–49.99 % | Voting rights33.33 % | FromJan 29, 2021 | ToAug 17, 2026 | | OwnerVÆKSTFONDEN | Ownership33.33–49.99 % | Voting rights33.33 % | FromMay 7, 2018 | ToApr 1, 2023 | | OwnerNordic Secondary Fund I P/S | Ownership5–9.99 % | Voting rights5 % | FromJan 29, 2021 | ToFeb 13, 2023 | | OwnerUddannelses- og Forskningsstyrelsen | Ownership10–14.99 % | Voting rights10 % | FromMay 23, 2017 | ToJan 29, 2021 | | OwnerGrac Société Simple | Ownership20–24.99 % | Voting rights20 % | FromMar 20, 2020 | ToJan 28, 2021 | | OwnerBOREAN INNOVATION A/S | Ownership5–9.99 % | Voting rights5 % | FromMar 24, 2014 | ToSep 3, 2019 | | OwnerVÆKSTFONDEN | Ownership20–24.99 % | Voting rights20 % | FromMay 23, 2017 | ToMay 6, 2018 | | OwnerRJOE INVEST ApS | Ownership5–9.99 % | Voting rights5 % | FromFeb 1, 2015 | ToMay 23, 2017 | | OwnerUddannelses- og Forskningsstyrelsen | Ownership25–33.32 % | Voting rights25 % | FromJan 1, 2017 | ToMay 22, 2017 | | OwnerHealthcare Ventures ApS | Ownership50–66.66 % | Voting rights50 % | FromFeb 1, 2015 | ToMay 22, 2017 | ## Ultimate owners [View ownership diagram](https://datapublica.dk/en/companies/35205500-cathvision-aps/portfolio) | Name | Ownership through | Calculated ownership | | --- | --- | --- | | Grac Société Simple | Direct | 33.33–49.99 % | | Danmarks Eksport- og Investeringsfond | Direct | 25–33.32 % | | Mads Emil Matthiesen | Healthcare Ventures ApS | 5–9.99 % | ## Company pages - [Overview](https://datapublica.dk/en/companies/35205500-cathvision-aps) - [Financial report](https://datapublica.dk/en/companies/35205500-cathvision-aps/financials) - [Risk](https://datapublica.dk/en/companies/35205500-cathvision-aps/risk) - [Timeline](https://datapublica.dk/en/companies/35205500-cathvision-aps/timeline) - [Ownership and relations](https://datapublica.dk/en/companies/35205500-cathvision-aps/portfolio) - [Production units](https://datapublica.dk/en/companies/35205500-cathvision-aps/production-units) - [Gazelle](https://datapublica.dk/en/companies/35205500-cathvision-aps/gazelle) - [Investments](https://datapublica.dk/en/companies/35205500-cathvision-aps/investments) - [Company website](https://cathvision.com/) ## Official sources - [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/35205500)